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Abstract
The genetic model of tumorigenesis by Vogelstein et al. (V theory) and the molecular definition of cancer hallmarks by
Hanahan and Weinberg (W theory) represent two of the most comprehensive and systemic understandings of cancer. Here,
we develop a mathematical model that quantitatively interprets these seminal cancer theories, starting from a set of
equations describing the short life cycle of an individual cell in uterine epithelium during tissue regeneration. The process of
malignant transformation of an individual cell is followed and the tissue (or tumor) is described as a composite of individual
cells in order to quantitatively account for intra-tumor heterogeneity. Our model describes normal tissue regeneration,
malignant transformation, cancer incidence including dormant/transient tumors, and tumor evolution. Further, a novel
mechanism for the initiation of metastasis resulting from substantial cell death is proposed. Finally, model simulations
suggest two different mechanisms of metastatic inefficiency for aggressive and less aggressive cancer cells. Our work
suggests that cellular de-differentiation is one major oncogenic pathway, a hypothesis based on a numerical description of
a cell’s differentiation status that can effectively and mathematically interpret some major concepts in V/W theories such as
progressive transformation of normal cells, tumor evolution, and cancer hallmarks. Our model is a mathematical
interpretation of cancer phenotypes that complements the well developed V/W theories based upon description of causal
biological and molecular events. It is possible that further developments incorporating patient- and tissue-specific variables
may build an even more comprehensive model to explain clinical observations and provide some novel insights for
understanding cancer.
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Introduction
Efforts to understand cancer have continued to intensify since
the start of a presidential campaign to conquer cancer in 1971 [1].
Mortality rates from cancer remains stubbornly high with more
than half a million deaths in the US alone in 2009 [2]. Cancer is
considered to be predominantly a genetic disease [3]. It is believed
that multiple sequential mutations induce malignant transforma-
tion of a normal cell into the cancer founder cell, which then
multiplies and evolves to become a clinically detectable tumor
[4,5]. This genetic model of carcinogenesis (referred to here as V
theory) is augmented by the elegant description of major cancer
features by Weinberg et al which is recognized as a seminal and
most comprehensive molecular definition of cancer [3,6]. We
specify these two seminal models collectively as the V/W theory of
cancer and have sought to develop a mathematical model capable
of quantitatively interpreting the V/W theory.
Epithelial tissues are the most common locus of oncogenesis.
However, individual epithelial cells are in a constant developmen-
tal process of tissue regeneration, namely from stem cell to
proliferating/differentiating cell and, finally, to senescent cells [7].
The short lifetime and continued proliferation of epithelial cells in
a tissue with a population of 1012 cells pose numerous challenges
to determining the natural course of oncogenesis. We have,
therefore, attempted to describe the life cycle of an epithelial cell
clone of endometrial origin as a normal physiological process to
serve as a basic reference for oncogenesis, which is made possible
by the addition of many genetic and environmental factors.
Clone lifetimes during normal epithelial cell regeneration
and some major assumptions for the study of
carcinogenesis
Endometrial cancer arises in the uterine epithelium, which even
in adults are undergoing constant turnover. The tissue stem cells
provide a stable cell source for tissue regeneration [7]. A stem cell
produces a progenitor cell committed to proliferation, resulting in
a clone with hundreds of descendant cells through many
generations of cell division. If we assume that the tissue stem cell
pool will provide as many progenitor cells as it needs at any time to
ensure tissue homeostasis (a stable total cell number), the life span
of a clone, from zero cell number (before the birth of a progenitor
cell) to one progenitor, to hundreds of descendant cells, to
senescence and eventually death, is a cycle from zero cells at the
beginning to zero cells at the end over a short time period, days or
months. A mathematical description of normal tissue regeneration
may identify immortalization (defying programmed senescence
and cell death) as an early deviation from the physiological process
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of genetic alterations and environmental stimulations [8]. It thus
creates mathematically a continuous and wide spectrum of
physiological and pathological cellular events with cancer at the
other end. The progenitor cell immediately born from a stem cell
and its descendant cells are defined as a clone and the entire
process (from 0 to 0) is defined as the clone lifetime. Thus, any
non-stem cell can be tagged and quantitatively analyzed according
to chronological time during a clone lifetime. Stem cells are
excluded for calculation since their number is maintained through
symmetric and asymmetric divisions in the stem cell compartment.
For uterine epithelium, there are millions of clones which are
actively cycling at any moment but at different stages of their clone
lifetime. This ensures a stable total cell number in a tissue for tissue
homeostasis.
The progression of a clone lifetime from the progenitor cell is
not only shown in the increase of cell number, but also in
accompanying differentiation. We derive a mathematical expres-
sion to describe the kinetics of a single cell during a clone lifetime.
Consequently, a tissue or any population of cells could be treated
as a composite of individual cells with cell-specific variables.
Cellular proliferation can be described in terms of density-
dependent growth
dN
dt
~f(t,N)N for some rate function f(t,N).
Tumor growth is often studied in the context of Gompertzian
growth, where f(t,N)~{blog(
N
K
), for constants b and K [9,10].
However, the Gompertz model is empirical and is based on data-
fitting with respect to tumor volume and weight for its description
of tumor growth [9,10], although mathematical explanations for
the appearance of this growth term have been proposed. In our
model we instead consider tumor size as a result of the
proliferation of its constituent cells. We derive a set of equations
to describe the lifespan of an individual cell within the mass. This
process allows us to describe intraclonal heterogeneity in response
to mutations and environmental stimulation.
Cellular proliferation is described through a cell’s proliferation
potential (a, with a unit of doublings per unit time) [11], and
occurs by the following:
n(t)~
ðt
tn
a(s)ds, ð1Þ
where a(t) is a cell’s proliferation potential and tn is the time the
cell was born. The function n(t) can be interpreted as a measure of
a cell’s status toward either dividing or dying. If n(t )~1 for some
time t~t  the cell divides, while if n(t )~{1 the cell dies. The
equation for n(t) is a consequence of the more common growth
terms
dN
dt
~ln(2)a(t)N(t),orequivalently,N(t)~2
(
Ð t
tn
a(s)ds)
, ð2Þ
which can be confusing in this context since we are discussing the
proliferation of a single cell and not an entire population. The
instantaneous a value for any cell in a tumor at any time of its
history is measurable theoretically and can be approximated in
practice with a mean value which is measured by the change of
cell number over a short time period [12]. Hayflick et al described
an individual cell’s capability to multiply as doubling potential
[13]. This concept was further expressed as proliferation potential
[14,15]. It was believed to be critically important to describe
intraclonal heterogeneity through description of the difference of
doubling potential of individual cells [13]. Consequently, intra-
clonal heterogeneity can be quantitatively described in a
population (a tissue or a tumor) through the summation of
individual cells even though all equations here are derived to
describe a single cell.
A clone lifetime, starting from a progenitor cell immediately
born from a stem cell can be mathematically expressed to capture
a dynamic interplay of proliferation and differentiation:
ap(t)~(1=L’):(L{g(t)):g(t) ð3Þ
kp(t)~Kmax:½1{e{K’:g(t) ð 4Þ
g(t)~ceiling(
ðt
0
Da(s)Dds) ð5Þ
where g(t) is the generation (g) at time t (a quantitative
measurement of lineage progression, related to cell division),
ap(t) is the generation-dependent programmed (inherent) a, and
kp(t) is the corresponding programmed differentiation coefficient
(k). The terms L, L’, Kmax and K’ are tissue type-specific
constants. Generally, L is designated as the maximal programmed
generation number before a cell enters a senescent phase
according to a cell’s inherent developmental program. L’ is the
tissue-specific conversion coefficient, which converts mathemati-
cally the value of generation to that of proliferation potential,
dictating the change of programmed proliferation potential value
according to a cell’s biological clock, a reading of progression of
generation. Kmax is the coefficient representing the maximal value
of differentiation in a tissue for the most mature cell, where greater
differentiation implies greater homeostasis according to Assump-
tion 1 below. K’ is the respective tissue-specific differentiation
conversion coefficient.
Proliferation and differentiation are integrated and continual
cell replacement processes in adult tissue homeostasis [7,16]. In
our model, ap during the developmental process can be described
as a gradual increase in its value, reaching the peak at the middle
of the developmental stage, and then undergoing a gradual
decrease until senescence. Meanwhile, kp increases gradually and
reaches a plateau (maximal level) when cells become well-
differentiated. The idea is that cells at the middle of the clone
lifetime are the most productive and specialization continues
throughout the lifetime. When gwL, ap becomes negative,
indicating that the cell should enter a process of senescence by
its inherent program. This cellular dynamic mimics the gradual
proliferation and differentiation process in uterine epithelium
during the menstrual cycle.
Here, we must introduce the following assumptions in order to
describe the transformation process of oncogenesis.
Assumption 1. We hypothesize that one of the most
important properties of a normal cell is the maintenance of a
programmed proliferation potential ap in a developmental stage-
specific manner: homeostasis in proliferation or cell number. We
define a cell’s ability to maintain ap as the resistance potential (r)
with the following.
r(t)~kp(t):(ap(t){a(t)), ð6Þ
where r(t) is the resistance potential and a(t) is the proliferation
potential at time t. The resistance potential works to bring a cell’s
a to its programmed level ap, and thus is defined as the force to
maintain homeostasis in proliferation. Resistance potential could
be executed by cell cycle regulators such as cyclin D1, cdk1, Rb,
Mathematical Model of Human Cancer
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arresting cell cycle or triggering apoptosis.
Assumption 2. A human cell has in excess of 3 billion base
pairs in its genome. Genetic alterations (or mutations), including
single and multiple base pair changes, chromosome translocation,
aneuploidy and epigenetic alterations, are broadly defined here as
any altered hereditary factor, with an enormous number of
possibilities. A genetic alteration’s effect mi on differentiation
status (numerically expressed as differentiation coefficient k)i s
given as the following:
k(t)~kp(t)z
X n
i~1
mi ð7Þ
where n is the number of genetic alterations accrued by the cell
during the proliferative process, and mi is the numerical value of a
genetic alteration, quantifying its effect on the differentiation
coefficient. The values mi follow a Gaussian distribution with
mean m and standard deviation s as mi*N(m,s). It has been
reported that differentiation status of a tumor can be quantitatively
defined and tumor subtypes can be classified accordingly [17].
Thus, quantitative change of tumor differentiation should arise
from accumulation of mutations according to the V theory of
tumorigenesis [4,5].
Assumption 3. A cell lives in a microenvironment filled with
various growth and anti-growth signals such as hormones, growth
factors, and cytokines. Spatial constraints could have a remarkable
effect on cell proliferation as well, especially when a cell is
proliferating rapidly (in the case of cancer [18,19]). The specific
effect on a cell by a particular signal is not fixed and not precisely
targeted. We assume that the collective effect of all signals on a
particular cell follows a Gaussian distribution: b*N(m,s). The
effect of b on cell proliferation is expressed by a dynamical change
in a. This effect, along with the resistance potential, combines to
alter a according to:
da
dt
~r(t)zb(t): ð8Þ
Instead of combining the assumptions above into a single
equation, we present the following four parts collectively as a
summary equation for the growth dynamics of an individual cell in
order to discuss them more intuitively:
n(t)~
ðt
tn
a(s)ds,
da
dt
~r(t)zb(t), r(t)~k(t):(ap(t){a(t)),
k(t)~kp(t)z
X n
i~1
mi:
ð9Þ
The clone size is then determined by the summation of all cells
within the clone growing according to these dynamics.
Results
In this section, we will explore tissue homeostasis, malignant
transformation, tumor evolution, an alternate mechanism for the
initiation of metastasis and the survival and establishment of
metastatic lesions. The focus will be on endometrial cancer. The
mathematical description of normal tissue regeneration is essential
to serve as a reference for the process of malignant transformation.
Epithelial cell turnover is a dynamic process involving billions of
cells and is presented here as a huge landscape with genetic insults
(lightning) and environmental stimulations (raining) having an
uneven effect on individual cells which will consequently serve as
the basis of heterogeneity of oncogenesis and tumor evolution
(Fig. 1).
The clone lifetime of uterine epithelial cells
We first simulated the developmental process of normal
epithelial cells in order to understand clone size, the lifespan of
every descendant cell, proliferation potential at any moment of
development, and more importantly, changes in differentiation
coefficient. For the simulations of uterine epithelium proliferation,
we set L~10, L’~7, Kmax~3:78, and K’~0:4 in equations 3 and
4, yielding the following system to describe an individual cell in a
clone lifetime:
ap(t)~(10{g(t)):g(t)=7 ð10Þ
kp(t)~3:78:½1{e({0:4g(t)) : ð11Þ
For the purpose of a more simplified and specific discussion, we
will use equations 10 and 11 to substitute for equations 3 and 4 in
all of the simulations presented in this paper.
Since endometrial cancer primarily occurs in postmenopausal
women, simulations of the normal developmental process in
uterine endometrium were conducted either in the absence of
estrogenic stimulation or in the presence of low amounts of
estrogen exposure. This is represented numerically by either a
neutral mean or a small positive mean value for the Gaussian
distribution for b, respectively. Numerical simulations, with the
specified values for L, L’, Kmax, and K’, suggest that the possible
maximal clone size from a single progenitor cell is about 29~512
(Fig. 2a). However, when either a neutral or small positive
environmental stimulation (b) is applied which acts randomly and
independently on individual cells every day, cell division in a clone
is no longer synchronized due to the differing I ˆ6 values for each
cell. Peak clone size and time for complete death of a clone vary
according to b values. In a hypothetical menopausal endometrium
without any hormonal effect (zero environment, Fig.2a), a clone
will remain at a stable cell number for many years before they
enter senescence. With a neutral environment, b*N(0,1) or
b*N(0,2), the life cycle of a clone was remarkably shortened
although clones took a similar amount of time to reach peak clone
size (Fig. 2a). When a positive environment, b*N(1,1) or
b*N(2,1), was applied, clone size increased dramatically and
the time required to reach the peak clone size and complete
senescence were substantially shortened (Fig. 2a).
The values of a and b which were set around 1=month and
1=month2, respectively, for a menopausal endometrium may seem
too low since many cancer cells double in 1–2 days in culture.
However, cancer cells are grown in strong stimulation in vitro with
10–20% fetal bovine serum. Our simulation thus far considers
conditions without or with a minimal environmental stimulation.
In order to get a sense for what a menstrual cycle will look like in
the term of cell proliferation, a strong b, b*N(60,6) or
b*N(90,9) or b*N(120,12), was used to simulate a monophasic
oral contraceptive where hormones were given for 21 days
(Fig. 2b). The clone size could be 10–1,000 times larger depending
upon the hormone levels, consistent with the observation of
hyperplasia during proliferative phase of a menstrual cycle. Cell
death was sudden when the hormones were withdrawn. However,
Mathematical Model of Human Cancer
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incorporate any interaction between fast growth of cells and
environment, which is simulated in a following section, and the
pharmacological effect of sudden hormone withdrawal on blood
vessels supporting the endometrial tissues, which is not considered
in this manuscript. Once again, the entire endometrial tissue is
composed of millions of clones at different stages of their clone
lifetime. Every clone starts with zero number and finished with
zero number over its entire clone lifetime, with tissue stem cells
producing progenitor cells at any moment and resulting in millions
of clones at active cycling. The stem cell compartment will not be
included in our calculations in this manuscript.
Malignant transformation during dynamic epithelial cell
development
Based on the above description of a clone lifetime, malignant
transformation (the process of a normal cell becoming a cancer cell),
is thus defined on the single cell level as a reduction of a cell’s
differentiation coefficient k (a process of de-differentiation). This is
a definition at the single cell level as opposed to the definition of
tumor or cancer in mass or tissue level. In the traditional definition, a
tumor is defined as a clinically detected mass, a cancer cell is defined
morphologically by pathological examination, and malignancy as its
statistical correlation with patient outcome.
In order to simulate the potential effect of mutations on
malignant transformation, one genetic alteration is assumed to
occur at every cell division based on data available in the literature
[5]. Every alteration occurs randomly and independently, and has
an effect on the differentiation coefficient following a Gaussian
distribution of m*N(m,s). In order to explore the quantitative link
between the high incidence of transient and dormant tumors, and
the mutation rate and environmental stimulations, we set m~0 and
s~0:1, consistent with the hypothesis that mutations could have
either a positive or negative effect on the differentiation status, and
that most mutations are passenger mutations with little effect.
Accumulation of genetic alterations should be discussed in a
setting that a cell has a short lifetime physiologically in an
epithelium ranging from days to months but the tissue has billions
of cells at any moment and many times more in a human’s
lifetime. Clearly, a cell accumulates genetic alterations during the
developmental process, with a well-differentiated cell (long living
with gw10) having the most alterations. Using the above values of
m and s, and with the specified values for L, L’, Kmax and K’, the
probability for a single cell to have a k~0 (complete de-
differentiation and thus malignant transformation) after 10
generations (11 mutations) is 4|10{30 (Table 1). Even assuming
1010 as the total number of cells in an epithelial tissue at any
moment, and a one year lifetime of an epithelial clone (a rough
Figure 1. Schematic illustration of some of critical steps of human oncogenesis. These steps are simulated by our model to interpret
prevailing genetic theories of cancer. Our model, consisting of a few simple equations, captures the landscape of normal uterine tissue regeneration
(simulated for menopausal uterine epithelium and menstrual cycle in Fig. 2), malignant transformation (reduction of differentiation coefficient by
genetic alterations in Table 1), occurrence of dormant/transient tumors (simulation of tumor incidence in Tables 2 and 3), tumor evolution (one
cascade of tumor evolution resulting in the selection of more aggressive cancer subpopulations in Fig.3), a potential mechanism of the initiation of
metastasis (simulated in Fig.4) and the development of clinically detectable metastatic lesions (simulated in Fig. 5). This model describes the
evolution of individual cells incorporating quantitative effects from genetic alterations and environment factors, and emphasizes the role of intra-
tumor heterogeneity in tumor evolution and metastasis.
doi:10.1371/journal.pone.0016859.g001
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woman has statistically no chance to harbor a fully transformed
cell through genetic alterations alone. The probability to get a cell
with k~0 is even smaller in a less-differentiated cell (gv10) since
its accumulated mutational load is small although its k value is
low. Although tissue turnover could be as short as several days in
some epithelia (e.g., colon crypts), a hundred fold increase in total
cell number in an individual’s lifetime could not overcome the rare
probability of complete malignant transformation by mutation
alone. Our model suggests that environmental factors and
evolution could play critical roles in the selection and immortal-
ization of partially transformed cells.
Tumor evolution: growth of a heterogeneous mass
consisting of cells with various differentiation coefficients
In order to simulate the evolution of a heterogeneous tumor, we
assumed that 4 masses have 1000 cells each at time t~0. Every
cell had an ap~0 and a starting a(0)*N(0,1). A neutral and
slightly varying environmental effect b was assumed to follow
b*N(0,1). We further assumed the distribution of k values in a
mass followed k*N(0,0), (2,1), (3,1) and (4,1), respectively. The
median mass with k~0 reached 1012 cells (the simulation limit
when a simulation was terminated) by 11 months (Fig.3a). The
median mass with k*N(2,1) reached the simulation limit by 15
months (Fig.3a). The median size of masses with k*N(3,1) was
more than 108 cells by 24 months (Fig.3a). In the contrast, almost
all cells in the mass with k*N(4,1) would have a strong resistance
potential to maintain an ap~0 due to high k values (a possible
least k value is about 1 according to the accumulated probability),
and a neutral growth stimulation could not produce any significant
change of tumor mass (Fig. 3a). While different values for L, L’,
Kmax, and K’ change the times when the simulations reach a
simulation limit, the overall dynamics remain the same.
For the mass with the original k*N(2,1), the majority of cells
with high k values did not grow much since their resistance
potential quickly neutralizes the initial proliferation potentials
(a(0)) and any growth stimulatory effect from growth signals (b)t o
maintain a(t) around ap level. It was cells with low k values that
lost their capability to maintain a(t) at ap level and multiplied
remarkably, contributing increasingly to the population of the
mass. The median k value of the mass declined quickly to reach
k~0 by 6 months (Fig. 3b), indicating that the overwhelming
portion of cells were those with k~0. Similarly, the median k
value reached 0.0337 by 21 months for the mass with the original
k*N(3,1), which is approximately the lowest value among the
original 1000 cells (Fig. 3b). Comparing to the original mass with
k*N(3,1), the mass with k*N(2,1) not only had a median k~0
but also the vast majority of cells were k~0 cells by 24 months,
forming a dominant subpopulation with growth advantage. The
final tumor with a size 1012 cells appeared to be homogeneous in k
values. These simulations indicate how a cell was selected due to
its k value when a mass grew. The presence of many cells with
k~0 in a mass will provide a potential for unlimited growth, due
to the lack of a resistance potential.
Figure 2. A clone life of the uterine epithelial cells. The life of a clone is perceived to start when a progenitor cell is borne from an asymmetrical
division of a stem cell at t~0. The progenitor cell multiplies to produce the clone (all descendant cells), whose cells exhibit developmental stage
specific features described by equations 10, 11 and 5. The clone size is calculated as the summation of all individual cells whose growth is governed
by system 9. The size of the entire uterine epithelium at any time will be the summation of all clones with different sizes. A b value is assigned to an
existing cell every day, randomly and independently. a. Simulations of postmenopausal endometrium. b~0 is used to simulate a hypothetical
scenario exhibiting no environmental exposure. Neutral b’s, b*N(0,1) and b*N(0,2), are used as representations of the microenvironmental effect
of postmenopause. A small positive b, b*N(1,1) and b*N(2,1), is introduced to reflect a chronic exposure to weak estrogenic stimulation.
b. Simulations of endometrium with monophasic contraceptives. A monophasic schedule of oral contraceptives is used to model the
menstrual cycle. Strong and positive b’s, b*N(60,6), b*N(90,9), and b*N(120,12), are applied for 21 days in the simulations for the representation
of oral estrogen and progestin. The interaction between fast cell growth and microenvironment, and the effect of sudden withdrawal of hormones on
blood vessels are not included.
doi:10.1371/journal.pone.0016859.g002
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and evolution of a dominant subpopulation, where the differen-
tiation coefficient in some cells is already zero (completely
transformed). Evolution during the early stage of tumorigenesis
is less prominent since the difference of k values is small among
cells. In this case, environmental factors play an important role in
the selection of cells with growth advantage. Therefore, with
continuous occurrence of mutations and several cascades of
evolution, a substantially transformed cell will emerge and expand
as a subpopulation. The entire tumor although still heterogeneous,
will become increasingly aggressive. Furthermore, as discussed
below, positive and strong stimulations can promote the growth of
cells with kw0, creating a clinically detectable mass consisting of
less aggressive cells (with substantially reduced but non-zero k
values).
Calculation of cancer incidences including subclinical
(dormant/transient) and clinically detectable tumors
According to the simulation of malignant transformation by
genetic alterations in Table 1, the chance of getting a cell with
k~2 is 6|10{8, suggesting that 60,000 cells would have a k~2
in a human’s lifetime with 1012 cells. We carried out simulations to
test how many cells among those with k~2 will escape senescence
and develop into tumors under certain stimulatory conditions. All
cells were already at the senescent stage (defined as g§11), and for
further simulations, we assumed an ap value of -2/month.
Hormonal stimulation could be very strong during the menstrual
cycle. However, we did not include strong cyclic estrogen but
instead included a slightly positive stimulation with b*N(3,1) and
b*N(4,1) to represent chronic exposure to a weak estrogen in a
menopausal woman. Simulations were also performed for various
mutational rates. Data shown in Tables 2 and 3 suggest that
escape of senescence and development of a mass is positively
related to the estrogenic stimulation and mutation rate with the
parameter values mentioned earlier. A positive stimulation
b*N(4,1) and higher mutation rate (2 mutations per generation)
would have 60,000 cells escaping senescence in an individual if the
condition lasted for 6 months, including 87 masses with more than
10 cells, 4 masses with more than 100 cells, 3 masses with more
than 1,000 cells, 2 masses with more than 10,000 cells, 2 masses
with more than 100,000 cells and 1 mass with more than
1,000,000 cells (Table 2). However, if the exposure lasted for one
year, the incidence of neoplasm would dramatically increase
(Table 3). An individual would have 60,000 cells escaping
senescence, 3,523 masses with more than 10 cells, 869 masses
with more than 100 cells, 424 masses with 1,000 cells, 286 masses
with more than 10,000 cells, 215 masses with more than 100,000
cells and 164 masses with more than 1 million cells. The latter
masses would be large enough to be detected in the clinic. When
the mutation rate was reduced to one per generation, or
stimulation down to b*N(3,1) or both, the incidence of tumors
with varying sizes was substantially less (Tables 2 and 3). Thus, the
incidence of clinical and subclinical forms of neoplasm is affected
by mutation rate and exposure to chronic stimulation. If these
factors can be quantified, then the incidence of cancer can be
predicted for any specific individual. As a general rule, the cancer
incidence either subclinical or clinical is positively correlated with
an individual’s age, hormonal stimulation and mutagenic
exposure. This simulation is consistent with reports that subclinical
forms of dormant and transient tumors could be commonly
present in an individual and the incidence could be much higher if
multicentric tumors are included [20–23].
An alternative potential mechanism of the initiation of
cancer metastasis: destruction of inter-cellular structure
resulting from massive cell death
Since a normal endometrium contains billions of cells, there are
multiple clones in different stages of their lifetime providing the
tissue a stable total cell number [24]. We hypothesize the existence
of many basic tissues. Each of them maintains a stable cell number
with a minimal number of developing clones. The maintenance of
a stable number of cells in a basic tissue is thus the most
fundamental phenomenon of homeostasis at the tissue level [24].
Any sudden increase in cell number (volume) of a tumor will elicit
negative reaction from the microenvironment either due to the
lack of factors essential for cell survival or due to physical and
biochemical disruption of the environment (spatial dependence).
Using equations 10 and 11, we arrived at the estimated stable cell
number of 18,800 for a basic tissue in the endometrium if a stable
cell number was defined as variation of cell number at ƒ5% at
any time. Obviously, a basic tissue consists of many clones at
different stages of their lifetime. To study the interaction between
growing cells and their environment, we introduced two concepts:
cellular impact (Ci) through which a cell exerts its effect on the
basic tissue, and ecological balance (B) which is the direct
reaction from the basic tissue. Ecological balance is a reciprocal
action to all cells’ impacts (
P
Ci) on a basic tissue.
For any individual cell, the instantaneous impact of the cell on
the basic tissue at time t is proportional to its rate of growth,
dNi
dt (equation 2), so
Ci~caiNi
Table 1. The probability of reduction of the differentiation
coefficient to below 0 or 2 by genetic alterations alone, given
a frequency of 1 alteration/generation.
Generation kp Prob. kƒ0 Prob. kƒ2
1 1.25 2|10{36
2 2.09 6|10{50 2|10{1
3 2.65 2|10{52 7|10{5
4 3.02 3|10{49 1|10{7
5 3.28 1|10{45 4|10{9
6 3.45 7|10{42 1|10{9
7 3.56 2|10{38 1|10{9
8 3.64 3|10{35 3|10{9
9 3.69 2|10{32 7|10{9
10 3.72 4|10{30 2|10{8
11 3.75 6|10{28 6|10{8
12 3.76 4|10{26 2|10{7
13 3.77 2|10{24 4|10{7
14 3.78 6|10{23 8|10{7
15 3.78 6|10{23 2|10{6
The generation specific k value for a cell is calculated according to the equation
11 and the generation number is derived from equation 5. The accumulated
probability for mutations to reduce the generation specific k value to 0 or 2 is
calculated according to equation 7. Since mi*N(0,0:1) are independent by
assumption, the random variable M~
Pn
i~1 mi is also normally distributed,
with M*N(0,0:1
ﬃﬃﬃ
n
p
). This table shows the probability P(MƒL{kp), where
L~0 or 2.
doi:10.1371/journal.pone.0016859.t001
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C~
X Ns
i~1
Ci~c(
X Ns
i~1
ai
Ni
Ns
)~camNs,
where am is the expected value of the ai’s. In a basic tissue, there is
a stable cell number, so it should hold that am&0. It follows that
C&0 in a basic tissue.
Ecological balance will not act on a specific cell as a direct
reaction to its Ci value, but will instead affect all cells in the basic
tissue in a stochastic fashion following a Gaussian distribution
using Bm and Bs values. Thus,
Bm~{Cm~(
X Ns
i~1
Ci)=Ns, ð12Þ
Bs~Cs~(
X Ns
i~1
(Cm{Ci)
2=Ns)
1=2, ð13Þ
In order to simulate a potentially negative effect from the
microenvironment on a fast growing tumor and investigate the
effect of differentiation coefficients on the growth, we conducted
simulations of four neoplastic cells with k~0, 0:5, 1 and 2 arising
in four separate basic tissues. They grew under identical conditions
with b1*N(1=month2,0:2) and an initial a(0)~1=month. The
environmental reactions to tumor growth, b2*N(Bm,Bs) were
calculated according to Equations 12 and 13, and assigned to
every surviving cell every day randomly and independently. Our
results showed that for the first 12 months, the cell with k~0
proliferated very fast and reached the median mass size of
approximately 170,000 cells by 5 months (Fig. 4a). A cell death of
more than 6000 cells occurred by 5 months (Fig.4b), which was
followed by a slow increase in mass size but accompanied by
increasing cell death. More than 7 million cells died while the mass
size reached only 680,000 cells by 12 months (Fig.4a and 4b),
suggesting that the number of cell deaths is more than 10 times the
mass size. The cell with k~0:5 proliferated and reached the
similar mass size by 12 months (Fig.4a). However, significant cell
death did not occur until the 9th month (Fig. 4b). The two cells
with k~1 and k~2 grew very slowly (Fig.4a) and did not have
any substantial cell death by 12 months (Fig. 4b).
The above simulations suggest an interesting possibility. Massive
cell death causes destruction in the tissue, resulting in widespread
cell relocation and rupture of blood vessels. Thus, we speculated
that massive cell death could lead to cell motility and tumor
expansion. Simulations conducted by Enderling et al suggests a
similar role of cell death for tumor expansion and invasion [19].
The simulations here showed that the faster proliferation of a more
Figure 3. Simulation of tumor evolution. Tumor size change and re-distribution of intra-tumor subpopulations are simulated. a. The growth
curve of four masses with 1000 heterogeneous cells each, specified by different differentiation coefficients to indicate the extent
of loss of differentiation. Every cell has an ap~0 and is assigned at t~0, randomly and independently, an a(0)*N(0,1) to indicate heterogeneous
initial proliferation potentials. Each mass has a k value for its cells from k*N(0,0), k*N(2,1), k*N(3,1), and k*N(4,1), respectively. All cells grow
at a neutral condition b*N(0,1). The tumor size is expressed as the total number of cells within a mass, with each individual cell proliferating
according to the system 9. A simulation is terminated when the total number of cells exceeds 1012. No mutation is considered thus the k value
remains constant for each cell and its descendants. b. Change of the values of differentiation coefficients over time in the four tumors.
The median k values over time among all the cells of one of 4 masses shown in Fig 3a are shown. The k values shown in the legend are the initial
distributions of k values within each of the four masses at time t~0.
doi:10.1371/journal.pone.0016859.g003
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overtly larger tumor but instead might result in earlier tissue
invasion and metastasis. This is consistent with clinical observa-
tions that an aggressive cancer does not often present as a solitary
large primary mass but a benign tumor does. As indicated by the
simulations, tissue invasion and metastasis might occur in the fifth
month when the mass size of k=0 tumor was approximately
170,000 cells.
However, the simulations above did not consider the positive
interactions between cancer cells and microenvironment. Cancer
cells may release some factors to enhance angiogenesis, and the
surrounding tissues may adjust to accommodate the growing mass.
These positive interactions may catch up to the increase in tumor
size and reach a new balance for further tumor growth. In
addition, a slowly proliferating tumor may have a good chance to
reach a new balance and achieve a larger tumor size without
metastasis.
Survival of metastatic cells in the circulation and
development of clinically detectable metastatic lesions
We now investigate the likelihood of cancer cell survival during
the metastatic process and the role of the differentiation coefficient
in the establishment of metastatic lesions. We assume that a cancer
cell takes 5 steps to reach an ectopic (distant) site and attain
Table 3. Simulation of the effect of mutation rate and
environmental factors on the incidence of neoplasm in an
individual.
Magnitude N(3,1),1=gN (3,1),2=gN (4,1),1=gN (4,1),2=g
§100 60,000 60,000 60,000 60,000
§101 0 0.48 728 3532
§102 0 0.1 30 869
§103 0 0.02 5 424
§104 0 0.01 2 286
§105 0 0 0.87 215
§106 0 0 0.5 164
As a continuation of Table 1, an individual was assumed to have an incidence of
60,000 cells with k~2 in his life time. These cells were assumed to be in
senescent stages (ap~{2) with slight proliferation potential (a(0)~0:2).
Different mutational rates, 1 (1m/g) or 2 (2m/g) per generation, and varying
environmental stimulations, b*N(3,1) or b*N(4,1) were used to investigate
the incidence of escape from senescence and development of different sizes of
masses by each of 60,000 cells. Exposure times to chronic stimulation were 6
months every year (Table 2) or all year around (Table 3). Simulations are run for
a period of 1 year. Outcome of 60,000 cells with k~2 under hormonal exposure
for 12 months.
doi:10.1371/journal.pone.0016859.t003
Table 2. Simulation of the effect of mutation rate and
environmental factors on the incidence of neoplasm in an
individual.
Magnitude N(3,1),1=gN (3,1),2=gN (4,1),1=gN (4,1),2=g
§100 60,000 60,000 60,000 60,000
§101 0 0 0.76 87
§102 0004
§103 0003
§104 0002
§105 0002
§106 0001
As a continuation of Table 1, an individual was assumed to have an incidence of
60,000 cells with k~2 in his life time. These cells were assumed to be in
senescent stages (ap~{2) with slight proliferation potential (a(0)~0:2).
Different mutational rates, 1 (1m/g) or 2 (2m/g) per generation, and varying
environmental stimulations, b*N(3,1) or b*N(4,1) were used to investigate
the incidence of escape from senescence and development of different sizes of
masses by each of 60,000 cells. Exposure times to chronic stimulation were 6
months every year (Table 2) or all year around (Table 3). Simulations are run for
a period of 1 year. Outcome of 60,000 cells with k~2 under hormonal exposure
for 6 months.
doi:10.1371/journal.pone.0016859.t002
Figure 4. Cell death during tumor progression. Four cells with k~0, k~0:5, k~1 and k~2=month, respectively, are growing in an identical
growth condition provided by a b1*N(1=month2,0:2), a weak and positive growth stimulation, and an identical initial proliferation potential
a(0)~1=month. Environmental reaction to tumor growth is based upon b2*N(Bm,Bs), which affects any cell in the basic tissue in a stochastic
fashion. The environmental reaction is defined as an ecological balance and is calculated according to equations 12 and 13. No mutation is included,
thus the k value remains constant for each cell and its descendants in the simulations. a. The mass sizes arising from the four cells with different k
values but identical b1 value and initial a value. b. The accumulated numbers of cell death are presented for the four masses with k~0, 0:5, 1 and 2,
respectively. The accumulated total cell death over 12 months for the cells with k~1 and k~2 are zero but presented at a value of 0.5 due to the
logarithm scale of the y-axis. A b2*(Bm,Bs) is calculated and assigned to each surviving cell every day.
doi:10.1371/journal.pone.0016859.g004
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to the main steps in the formation of a metastasis [25]. Each step is
rate-limiting and modeled as negative growth stimulation. Three
masses each had 10,000 cells migrating to a distant site and their k
values for every one of 10,000 cells were k~0, k~1, and k~2,
respectively (Fig. 5). The implemented b values for each rate-
limiting step are: b*N({6=month2,0:2) representing dissemina-
tion at the primary site for 3 days, b*N({10=month2,0:2)
representing intravasation for 2 days, b*N({20=month2,0:2)
representing circulation for 1 day, b*N({10=month2,0:2)
representing extravasation for 2 days, and survival at the ectopic
site with b*N({6=month2,0:2) for 3 days, following a similar
schedule in experiments [26]. Metastasis is assumed to be followed
by a b~0 for 5 years without distinguishing favorable and
unfavorable sites. Cells from the three masses have shown a
striking difference in their survival and establishment of metastatic
lesions. The survival rate at the end of the metastasic cascade (after
11 days) is similar among the three masses with more than 90%
survival (Fig. 5a and 5b), consistent with experimental data
showing that majority cells survive the metastatic process [26,27].
However, the mechanism for metastatic inefficiency is different
among cells with different levels of malignancy. A more malignant
cell (with k~0) was more vulnerable to the harsh conditions
during metastasis and had the lower survival rate (Fig. 5b). Only
19 (0.19%) out of 10,000 cells with k~0 survived, consistent with
metastatic inefficiency primarily due to subsequent cell death resulting
from apoptosis [28,29]. The surviving rates for cells with k~1 and
k~2 were 1.3% (132 out of 10,000) and 11.8% (1179 out of
10,000), respectively (Fig. 5b). But none of them could retain
sufficient growth to develop into a clinically detectable metastatic
lesion over 5 years (Fig.5a), which is consistent with the mecha-
nism of metastatic inefficiency due to failure of subsequent growth
[26]. Only those cancer cells with k~0 could grow into a
metastatic lesion after a successful metastasis (Fig. 5a). Cells with
k§1 remained dormant without further mutations and environ-
mental stimulations. Thus, establishment of clinically significant
ectopic lesions correlates positively with the number of cells with
extremely low k value in a primary tumor and the fast growth of
the primary tumor (Fig. 4), but negatively with the extent of harsh
conditions in the metastatic process (Fig.5). This result is consistent
with the well-established role of metastatic lesions to predict
patient outcome. But our model provides an approach to
quantitatively and prospectively predict the chance of a metastatic
lesion through analysis of the primary tumor, and may be
particularly useful to predict the existence of micrometastasis. For
cells with kw0 to grow in ectopic sites, a positive b is required.
The value of b determines whether an ectopic site is favorable for
the development of metastatic lesions. Thus, the long-held
hypothesis of seed and soil for pathogenesis of metastasis [25,29] is
quantitatively modeled here.
These results are also consistent with clinical observations that
metastatic endometrial cells are not cancer cells in endometriosis.
Endometrial cells undergo a fast proliferation during the early
menstrual cycle due to estrogenic stimulation and massive cell
death occurs late in the cycle due to withdrawal of hormones.
Some endometrial cells are transported through fallopian tubes
and implanted on the surface of the pelvic cavity. These
endometrial cells survive the metastatic process and the condition
in ectopic sites due to their high differentiation coefficient. As with
cells in the primary site, ectopic endometrial cells only proliferate
Figure 5. Modeling of cancer cell survival. The metastatic process and the development of clinically detectable metastatic lesions are simulated.
The number of cells surviving over the course of a metastatic process is shown. Three masses of 10,000 cells each attempt migration to a distant site,
with all cells within a mass possessing either k~0, k~1, and k~2, respectively. Every cell has an initial a(0)*N(0,1) and must pass 5 steps, which are
assumed to be negative for any cell to grow. Every step has its specific b value: dissemination at the primary site b*N({6=month2,0:2) for 3 days,
intravasation b*N({10=month2,0:2) for 2 days, circulation b*N({20=month2,0:2) for 1 day, extravasation b*N({10=month2,0:2) for 2 days, and
survival at the ectopic site b*N({6=month2,0:2) for 3 days. a. Cancer cell growth is followed for 5 years to show clinically detectable lesions. b. The
same cancer cells are followed for only 30 days in order to show the number of surviving cells when they reached distant sites (t~11 days). The
surviving cell number is the summation of all cells whose growth is governed by system 9. No further mutation is considered thus the k value remains
constant for each cell and its descendants in the simulations.
doi:10.1371/journal.pone.0016859.g005
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at the proliferative phase of a menstrual cycle, similar to those
modeled at Fig. 2b. The ectopic endometrial tissues become
atrophic with prolonged progestin treatment, pregnancy and at
menopause. Thus, the occurrence of endometriosis is due to 1)
successful metastasis due to mechanical transportation of endo-
metrial tissues into ectopic locations; 2) high survivability of cells
due to their high differentiation coefficient; and 3) periodic
proliferation stimulated by strong and cyclic hormones. Most
important of all, these ectopic endometrial cells have high k values
and are not cancer cells.
Discussion
It has been the hope of every cancer researcher that complex
cancer biology can be rationalized based on a small number of
underlying principles which govern the myriad cancer genotypes
and phenotypes [3,30]. The exceptional elucidation of the general
principles of cancer formulated by Hanahan and Weinberg, here
referred to as the W theory [6], coupled with efforts to elucidate
the mechanisms leading to carcinogenesis exemplified by the
seminal work of Vogelstein and colleagues, here referred to as the
V theory [4,5], combine to provide a solid heuristic foundation,
referred to here as V/W. Our model, using simple mathematical
equations featuring a small number of variables, is an attempt to
quantitatively and prospectively interpret V/W. It is also an
attempt to develop a classical insight and theory approach wherein
principles and equations are derived from fundamental concepts
and deductions as opposed to a direct a priori analysis of data
followed by an a posteriori explanatory model.
Assuming in our model that cells targeted for malignant
transformation include well-differentiated cells, malignant trans-
formation can be considered to be a process of de-differentiation
[17], which can be quantitatively described by a differentiation
coefficient. As illustrated at Fig. 1, numerous mutations occur in a
tissue with billions of cells constantly turning-over. Most non-stem
uterine epithelial cells have a lifespan limited to days or months.
The cumulative effect of mutations is neutral and not transfor-
mative in vast majority of normal cells since the mutational effect
follows a Gaussian distribution as proposed by our model. One out
of billions of cells acquires a mutation, or several mutations, which
result in de-differentiation, which is captured in a differentiation
coefficient, k in our model (equation 7). A reduced k value results
in a lower resistance potential (equation 6), which will allow the
cell to multiply in a subnormal level of hormonal (or other)
stimulation (system 9) and create a population of cells well beyond
homeostasis that might initially be hyperplastic or benign.
Additional mutations can further reduce cells’ k values yielding
selective fitness and a dominant sub-population due to their lower
k values (Fig.3). A lower k value corresponds to further de-
differentiation thus further malignant transformation. Again, some
cells in this population will emerge with even lower k values and
continue the cascade of malignant transformation and tumor
evolution. This mathematical expression of multistage oncogenesis
is strikingly complementary to the V theory [4,5]. Additionally, as
simulated in the Fig. 4, rapid growth of an increasingly malignant
cell population will be accompanied by massive cell death thus
creating a potential mechanism of metastasis that does not require
but facilitate further mutations. This result provides a quantitative
interpretation of Jones’ genomic analysis [5] opposing the long
held paradigm that the appearance of metastatic cell populations is
driven by additional mutations [4,5].
The V theory of tumorigenesis posits the fundamental role of
genetic mutations in malignant transformation as the pathway for
tumor progression. While it is likely that only a small number of
mutations are driver mutations and the rest are passengers, our
model accounts for the contribution of every potential mutation in
a normal distribution and, from this, the collective roles played by
all mutations can be quantified. The precise contribution of a
specific mutation has to be analyzed in patient samples [12].
Sequencing of many tumor genomes is increasingly being realized
with the initiation of Cancer Genome Altas and Cancer Genome
Anatomy project.
Tumor evolution is described by many investigators analogously
to Darwinism with tumors being a clonally-derived cell populations
and progression the result of some cells acquiring advantages
through mutations [31,32]. The descriptive theories are comple-
mented by our quantitative analysis that has a potential to interpret
awiderangeofdifferentcancerphenotypes.Useofourmodeleither
in population level or single cell level may prove useful in the
reconciliation of some seemingly contradicting observations.
Advancing age is the most potent of all carcinogens [33]. On the
other hand, cellular senescence (ageing) is as potent as apoptosis in
suppressing spontaneous tumorigenesis [34]. In our model the
probability of malignant transformation increases significantly as
generations progress at the single cell level. However, senescence
significantly increases when generation progresses (equation 3).
These factors play against each other and the balance will be shifted
to favor transformation if environmental stimulation increases to
escape senescence by providing cell proliferation beyond intrinsic
potential. At the tissue level, the probability of emergence of a
malignant cell will increase with age since an older individual will
have more cell cycles in their lifetime and, consequently, increased
cancer incidence.
Our model uses cellular generations as a biologic clock which is
a fundamental variable in determining cellular proliferation and
differentiation. While cell division is intuitively simple and clear
from a morphological perspective, a mathematical expression is
necessary to provide a usable description of propagation of an
individual cell during a clone lifetime. Cell divisions are
determined by proliferation potential that depend on proliferation
history and specific factors, such as mutations and environmental
cues. This approach allows us to follow the time course of a cell
during a clone lifetime without a need for counting cell divisions
experimentally, therefore measuring intra-tumor heterogeneity at
any time quantitatively. A proposed generation limitation is a
quantitative interpretation of replicative senescence.
Our model simultaneously describes individual cells as well as
cell populations (or tumors), thus preserving population heteroge-
neity. This approach captures qualitative change in individual cells
as the critical event for tumor progression (cascade of tumor
evolution). This additive approach to summarizing individual cells
may allow us to prospectively describe incidences of dormant/
transient cancers (those cancers either not easily diagnosed
clinically or not diagnosed at all [20,23]). In the future, detailed
comparison between lethal cancer and non-disease cancer will be a
much more informative way in which to identify truly causal
genetic alterations. In a normal physiologic scenario, growth of a
clone or an individual cell of the clone will have minimal effect on
the environment. However, growth of a malignant mass is fast and
can be extensive, exceeding normal physiological limits. Thus, the
impact of the mass on its surroundings will be significant and,
conversely, the reaction of the surrounding environment will also
be dramatic (equation 12). This will cause massive cell death
(Fig. 4), here identified as a potential mechanism of the initiation of
metastasis.
Our model is best described as a classic theoretical model of
insight and theory approach and the coherence of the model is fully
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and still at an early stage of development. Numerous tissue- and
cell- specific variables have to be quantitatively determined before
such a model can be experimentally applied to a wide range of
cancer phenomena. Modeling of environment effects in this model
also will require modification over time. Fortunately, there are
many excellent models regarding the role of environment factors
in oncogenesis and tumor progression [35–39]. Our hope is that
we may be able to integrate our model with those existing models.
Such a theoretical approach should be complimentary to empirical
and bioinformatic approaches to cancer research in a way that
data are used iteratively to test and update equations and laws.
Taken together, our modeling of malignant transformation and
tumor progression, based on a few assumptions and a few
mathematical equations, is capable of comprehensively describing
major cancer phenotypes and has suggested some interesting
features for neoplasm: 1) incidence of neoplasm is much higher
than what is diagnosed in clinics due to the frequent existence of
dormant/transient neoplasm; 2) neoplastic cells are heterogeneous
in a tumor and the aggressive cells (with low differentiation
coefficients) have a growth advantage that allows them to
dominate the tumor during its evolution; 3) rapid proliferation
can result in cell death and lead to cell dislocation and metastasis;
4) more aggressive cancer cells have less chance to survive
metastasis but are more capable of growing into a clinically
significant lesion. Therefore, an aggressive tumor, defined by the
presence of cancer cells with low differentiation coefficients, will
have a poor patient outcome since the significant number of k&0
cells will ensure fast growth in the primary and ectopic sites in
most environmental conditions.
Methods
The Model
In this paper, we discuss a fundamental model for cancer that
has shown the capability to systematically capture many varied
cancer phenotypes. The quantitative interpretation of oncogenesis
is preceded by a comprehensive description of normal tissue
regeneration in uterine epithelium, based on the assumption that
every one of billions of normal cells follows an inherent program
for proliferation and differentiation through a cellular interpreta-
tion of chronological time. The landscape of physiological tissue
regeneration provides a picture of normal cell heterogeneity and
dynamics, and serves as the reference for tumor development
resulting from genetic insults and environmental stimulations. It is
a single-cell based model, where the evolution of each tumor is
described in terms of the evolutionary dynamics of its constituent
cells. The quantitative basis of the model is a quantification of a
cell’s differentiation status, a measurement of how ‘‘normal’’ a cell
is, and how this status varies due to different mutations. The
cellular dynamics are defined on a per cell basis by the system of
equations:
n(t)~
ðt
tn
a(s)ds,
da
dt
~r(t)zb(t), r(t)~k(t):(ap(t){a(t)),
k(t)~kp(t)z
X n
i~1
mi,
where a(t) is a cell’s proliferation potential at time t and k(t) is its
differentiation coefficient. The parameters mi are the mutational
effects on the differentiation coefficient, and are distributed
according to a Gaussian distribution with mean m and standard
deviation s, mi*N(m,s). The parameter b(t) is the environmental
effect and is considered as an overall effect over the course of one
day, and is also chosen from a Gaussian distribution. Each cell has
associated with it certain programmed levels of proliferation
potentials, ap(t)~(1=L’):(L{g(t)):g(t), and differentiation coeffi-
cients, kp(t)~Kmax½1{e({K’:g(t)) , which are dependent on the
maturity of the cell, measured by its generation number,
g(t)~ceiling(
ðt
0
Da(s)Dds). The resistance potential (r(t))i sa
restorative force, acting to restore a back to its programmed level.
A measure of the cell’s status toward either dividing or dying is
provided by n(t), where the cell was born at time tn. This system of
equations is valid over the lifetime of the cell, that is, from the time
it is born (tn) until it either dies (n(t)~{1) or divides (n(t)~1). In
the case that the cell divides, the two daughter cells inherit a, k,
and g from the parental cell. Each cell then proliferates
independently of the other according to this system of equations.
The developmental process continues with cell-specific b’s, and the
mutations accumulated by each daughter cell are independent of
those accumulated by the other daughter cell.
In all of the simulations presented in this manuscript, we
consider the model case where L~10, L’~7, Kmax~3:78, and
K’~0:4, so that the programmed proliferation potentials and
differentiation coefficients are given by ap(t)~(10{g(t)):g(t)=7
and kp(t)~3:78:½1{e({0:4g(t))  respectively. In all cases consid-
ered in this manuscript, we arbitrarily take mi*N(0,0:1).
However, the frequency of these mutations and the distributions
for the environmental effects vary among the experiments
considered.
Each simulation is performed using the computer programming
language Fortran 90, with the resulting graphics generated with
Matlab. The time-step for each simulation is dt~1=30. Over the
course of one time-step, the system can be solved explicitly, with
an algorithm outlining this process provided as Supporting
Information S1. At time tn,ab is chosen for each cell, and a, n,
and g are advanced over dt. If the cell advances in generation
number (gnewwgold), the cell gains a number of mutations,
dependent on the experiment. If n§1, the cell has proliferated,
with the (2floor(n)) daughter cells inheriting the parent’s a and k.I f
nƒ{1, then the cell is considered dead and is removed from the
simulation.
The clone lifetime of uterine epithelial cells
In this section, we consider two experiments. The first
experiment, illustrated by Fig. 2a, is an analysis of the clone size
in uterine epithelium when there is little or no estrogen exposure.
A b value is assigned to an existing cell every day, randomly and
independently. Four different trials are considered: b~0,
b*N(0,1), b*N(0,2), and b*N(1,1). 101 simulations were
performed for each trial, with Fig. 2a illustrating the median
curves for each trial, and the maximal, 75th percentile, the
median, 25th percentile, and the minimal sizes of clones are
presented in Fig. S1.
The second experiment,illustrated byFig.2b,isan analysis ofthe
clone size in uterine epithelium with the presence of monophasic
contraceptives. The exposures to large concentrations of estrogen
are represented here by strong and positive b’s. Three trials are
considered: b*N(60,6), b*N(90,9),a n db*N(120,12). These
environmental effects are applied for 21 days before being removed.
As in the previous figures, 101 simulations were performed for each
trial and the median clone sizes are presented. All experiments are
performed in the absence of mutations. The maximal, 75th
percentile, the median, 25th percentile, and the minimal sizes of
clones are presented in Fig. S2.
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According to this model, the differentiation coefficients are
altered solely due to mutations. In this section, we consider the
accumulated probabilities of a cell to attain a differentiation
coefficient of kƒ0 or kƒ2 after n generations. We assume that
one mutation occurs per generation, with each mutation
being random and independent, with mi*N(0,0:1). Since the
mutations are independent by assumption, the random
variable M~
Pn
i~1 mi is also normally distributed, with
M*N(0,0:1
ﬃﬃﬃ
n
p
). Table 1 shows the probability P(MƒL{kp),
where L~0 or 2.
Tumor evolution: growth of a heterogeneous mass
consisting of cells with various differentiation coefficients
In this section, the evolution of a mass comprising cells with
various differentiation coefficients is explored. Four separate trials
are considered. Each trial begins with 1000 cells that have
reached maturity, that is, ap~0. Each cell is assigned a
proliferation potential with a(0)*N(0,1). Every cell was assigned
a k-value from either N(0,0), (2,1), (3,1) and (4,1), depending on
the trial. Only nonnegative k values are considered in this paper,
so if kv0,w es e tk~0. No mutations were considered, and
therefore each cell and its descendants retained their initial k-
value. For each cell, the environmental effects were chosen with a
neutral mean, b*N(0,1). The simulations were performed until
either a simulation period of 2 years had passed or the total cell
number had reached 1012. Fig. 3a represents the median mass
sizes of 101 simulations among each of the four trials, while
Fig. 3b illustrates the evolution of the median k-values of the cells
within the median masses of each trial. The maximal, 75th
percentile, the median, 25th percentile, and the minimal values of
mass sizes and k values are presented in Fig S3 and S4,
respectively.
Calculation of cancer incidences including subclinical
(transient and dormant) and clinically detectable tumors
In Table 1 it is shown that, for the test case, the probability of a
specific cell reaching kƒ2 due solely to mutations by the time it
reaches programmed senescence, that is apv0 after 11 genera-
tions, is 6|10{8. Assuming that there are roughly 1010 epithelial
cells at any time, each with a lifespan of 1 year, a human with a
lifetime of 100 years would have 1012 epithelial cells throughout
their lifetime, with roughly 60,000 cells having kƒ2 due solely to
mutations. In this section, we analyze the evolution of these 60,000
cells to calculate empirical probabilities of having masses of various
orders of magnitude during a lifetime. Two separate experiments
are considered, each with four separate trials. In both experiments,
we begin with 60,000 cells, each with k~2. The cells begin at the
senescent stage, with ap~{2. However, their actual proliferative
potential is a(0)~0:2. In the first experiment, there is an
environmental effect present for six months every year, while in
the second experiment, the environmental effect is present year-
round. The four trials for each experiment have either one or two
mutations per generation, and an environmental effect following
b*N(3,1) or b*N(4,1). For each trial, 101 simulations are
performed, and empirical probabilities are calculated from the
data generated. The mean number of tumors of various sizes that
can be expected among the 60,000 cells are illustrated when the
probability of having at least one tumor of each magnitude was
one. In the case that a tumor cannot be probabilistically
guaranteed, the probability of having at least one tumor of each
magnitude is illustrated.
An alternative potential mechanism of the initiation of
cancer metastasis: destruction of intercellular structure
resulting from massive cell death
In this section, the reaction of the microenvironment surround-
ing the tumor is included into the model as an additional
environmental effect. The impact of a cell on its environment (Ci)
is proportional to its rate of growth
dNi
dt
,s oCi~cai(t)Ni. The total
environmental impact of a tumor is then
C~
X Ns
i~1
Ci~c(
X Ns
i~1
ai
Ni
Ns
)~camNs,
where am is the expected value of the ai’s. The environmental
response to this cumulative force acts on each cell in a stochastic
fashion, with mean Bm~{Cm~(
PNs
i~1 Ci)=Ns and standard
deviation Bs~Cs~(
PNs
i~1 (Cm{Ci)
2=Ns)
1=2. Fig. 4 illustrates
the outcomes of four trials. Each trial begins with one cell. A weak
growth stimulation following b1*N(1,0:2) is chosen, with this
value being the initial environmental effect for all four trials. Their
initial proliferation potentials are all identically a(0)~1. However,
their initial differentiation coefficients differ, with either k~0, 0:5,
1,o r2. No mutations are considered, so these k-values remain
constant among all descendant cells. At each time step, a new
growth stimulation b1*N(1,0:2) and environmental reaction
b2*N(Bm,Bs) are calculated. One hundred and one simulations
were performed for each trial, and Fig. 4 illustrates the median
curves for the mass sizes and the accumulated number of cell
deaths occurring for each trial.
Survival of metastatic cells in the circulation and
development of clinically detectable metastatic lesions
In this section, the likelihood of cancer cell survival during the
metastatic process is explored, along with the role of the
differentiation coefficient in the establishment of a metastatic
lesion. The cancer cells are assumed to take five steps to reach an
ectopic site and establish a metastatic lesion. The five steps are
represented by negative growth stimulations. Three trials are
considered. Each trial begins with 10,000 cells. The k-values of all
10,000 cells are either k~0, 1,o r2, depending on the trial. No
mutations were included, so all descendants retained the same
k-value. Their initial proliferation potentials are chosen from
a(0)*N(0,1). Each cell underwent the following environmental
effects over the course of the five steps: b*N({6,0:2) for 3 days
representing dissemination at the primary site, b*N({10,0:2) for
2 days representing intravasation, b*N({20,0:2) for 1 day
representing circulation, b*N({10,0:2) for 2 days representing
extravasation, and b*N({6,0:2) for 3 days representing survival
at the ectopic site. This was followed by an environmental effect of
b~0 for 5 years. 101 simulations were performed for each, with
the median curves for the number of surviving cells illustrated in
Fig. 5. The maximal, 75th percentile, the median, 25th percentile,
and the minimal values of mass sizes are presented in Fig S5.
Supporting Information
Figure S1 A clone lifetime of uterine epithelial cells
during menopause, illustrated by change of cell number
of the clone over time. 101 simulations are performed for all
cases, with the following trajectories presented here: minimum,
25th percentile, median, 75th percentile, and maximum. (a)
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PLoS ONE | www.plosone.org 12 March 2011 | Volume 6 | Issue 3 | e16859Results for b~0. (b) Results for b*N(0,1). (c) Results for
b*N(0,2). (d) Results for b*N(1,1). (e) Results for b*N(2,1).
(EPS)
Figure S2 A clone lifetime of uterine epithelial cells with
oral contraceptives, illustrated by change of cell number
of the clone over time. 101 simulations are performed for all
cases, with the following trajectories presented here: minimum,
25th percentile, median, 75th percentile, and maximum. (a)
Results for b*N(60,6). (b) Results for b*N(90,9). (c) Results for
b*N(120,12).
(EPS)
Figure S3 Simulations of tumor evolution: size change
of intra-tumor subpopulations of tumors with heteroge-
neous cells. The growth curves of four masses with 1000
heterogeneous cells each, specified by different differentiation
coefficients to indicate the loss of differentiation. 101 simulations
are performed for all cases, with the following trajectories
presented here: minimum, 25th percentile, median, 75th percen-
tile, and maximum. (a) Results for k~0. (b) Results for k*N(2,1).
(c) Results for k*N(3,1). (d) Results for k*N(4,1).
(EPS)
Figure S4 Simulations of tumor evolution: redistribu-
tion of k-values among intra-tumor subpopulations of
tumors with heterogeneous cells. Change of the median
value of differentiation coefficients with respect to time for the
masses presented in Figure 3. (a) Results for k~0. (b) Results for
k*N(2,1). (c) Results for k*N(3,1). (d) Results for k*N(4,1).
(EPS)
Figure S5 Modeling of cancer cell survival during
metastasis and the establishment of metastatic lesions.
101 simulations are performed for all cases, with the following
trajectories presented here: minimum, 25th percentile, median,
75th percentile, and maximum. (a) Results for k~0. (b) Results for
k~1. (c) Results for k~2.
(EPS)
Supporting Information S1 Computational Algorithm
and Additional Figures for ‘‘Quantitative Interpretation
of a Genetic Model of Carcinogenesis Using Computer
Simulations’’.
(PDF)
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